Cell 181 (2), 424441 (2020)
doi: 10.3389/fmolb.2025.1724944 Received 14 October 2025 Revised 18 November 2025 Accepted 30 November 2025 Published 18 December 2025 Volume 12 - 2025 Edited by Maria Barile, University of Bari Aldo Moro, Italy Reviewed by Anna Maria Giudetti, University of Salento, Italy Maria Tolomeo, National Research Council (CNR), Italy Updates Copyright 2025 Schrder, Jalilvand, Kahl, Kaiser and Liebau
Auxiliary value of receptor antagonists in the treatment of secondary fatty liver In addition, propranolol can reduce the peripheral lipolysis rate (with a 32% decrease in Ra FFA) in burn patients complicated with fatty liver, while maintaining the hepatic very low-density lipoprotein-triglyceride secretion rate to prevent fat accumulation in hepatocytes
What is GHK Cu Peptide Injection GHK-Cu Peptide injection is an emerging copper peptide therapy that has attracted interest for its potential regenerative and anti-aging effects
Results vary from person to person based on their current health status, diet, and stress levels
Correspondingly, genetic causal analysis identified CD28CD25++ CD8+ T cells as playing a crucial intermediary role in the relationship between elevated levels of 5-oxoproline and increased lung adenocarcinoma risk